Atopic dermatitis: Burden of illness, quality of life, and associated complications

Allergy and Asthma Proceedings

Volumn 38, Issue 1, 2017, Pages 3-8

  Drucker, Aaron M ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASTHMA; ATOPIC DERMATITIS; CLINICAL PRACTICE; COMORBIDITY; DISEASE SEVERITY; EMOTIONAL STRESS; FOOD ALLERGY; HEALTH CARE COST; HUMAN; INFECTION RISK; PATHOGENESIS; PREVALENCE; QUALITY OF LIFE; RHINITIS; SUICIDAL IDEATION; COST OF ILLNESS; DERMATITIS, ATOPIC; FAMILY; HEALTH SURVEY;

COMORBIDITY; COST OF ILLNESS; DERMATITIS, ATOPIC; FAMILY; HUMANS; POPULATION SURVEILLANCE; PRACTICE PATTERNS, PHYSICIANS'; PREVALENCE; QUALITY OF LIFE;

EID: 85008500285     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2017.38.4005     Document Type: Article

References (70)

1. Silverberg JI, and Hanifin JM. Adult eczema prevalence and associations with asthma and other health and demographic factors: A US population-based study. J Allergy Clin Immunol 132:1132-1138, 2013.
2. Drucker AM, Li WQ, Lin L, et al. Atopic dermatitis (eczema) in US female nurses: Lifestyle risk factors and atopic co-morbidities. Br J Dermatol 174:395-1397, 2016.
3. Hanifin JM, Reed ML, and Eczema Prevalence and Impact Working Group, et al. A population-based survey of eczema prevalence in the United States. Dermatitis 18:82-91, 2007.
4. Margolis JS, Abuabara K, Bilker W, et al. Persistence of mild to moderate atopic dermatitis. JAMA Dermatol 150:593-600, 2014.
5. Abuabara K, Hoffstad O, Troxel A, et al. Atopic dermatitis disease control and age: A cohort study. J Allergy Clin Immunol 136:190-192.e3, 2015.
6. Kim JP, Chao LX, Simpson EL, and Silverberg JI. Persistence of atopic dermatitis (AD): A systematic review and meta-analysis. J Am Acad Dermatol 75:681-687, 2016.
7. Shaw TE, Currie GP, Koudelka CW, Simpson EL. Eczema prevalence in the United States: Data from the 2003 National Survey of Children's Health. J Invest Dermatol 131:67-73, 2011.
8. Silverberg JI, Garg NK, Paller AS, et al. Sleep disturbances in adults with eczema are associated with impaired overall health: A US population-based study. J Invest Dermatol 135:56-66, 2015.
9. Murray CJ, Atkinson C, Bhalla K, et al. The state of US health, 1990-2010: Burden of diseases, injuries, and risk factors. JAMA 310:591-608, 2013.
10. Hay RJ, Johns NE, Williams HC, et al. The global burden of skin disease in 2010: An analysis of the prevalence and impact of skin conditions. J Invest Dermatol 134:1527-1534, 2014.
11. Horii KA, Simon SD, Liu DY, and Sharma V. Atopic dermatitis in children in the United States, 1997-2004: Visit trends, patient and provider characteristics, and prescribing patterns. Pediatrics 120:e527-e534, 2007.
12. Silverberg JI. Health care utilization, patient costs, and access to care in us adults with eczema: A population-based study. JAMA Dermatol 151:743-752, 2015.
13. Bickers DR, Lim HW, Margolis D, et al. The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. J Am Acad Dermatol 55:490-500, 2006.
14. Chamlin SL, Frieden IJ, Williams ML, and Chren MM. Effects of atopic dermatitis on young American children and their families. Pediatrics 114:607-611, 2004.
15. Covaciu C, Bergstrom A, Lind T, et al. Childhood allergies affect health-related quality of life. J Asthma 50:522-528, 2013.
16. Misery L, Finlay AY, Martin N, et al. Atopic dermatitis: Impact on the quality of life of patients and their partners. Dermatology 215:123-129, 2007.
17. Beattie PE, and Lewis-Jones MS. A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases. Br J Dermatol 155:145-151, 2006.
18. Magin P. Appearance-related bullying and skin disorders. Clin Dermatol 31:66-71, 2013.
19. Zuberbier T, Orlow SJ, Paller AS, et al. Patient perspectives on the management of atopic dermatitis. J Allergy Clin Immunol 118:226-232, 2006.
20. Holm EA, and Jemec GB. Time spent on treatment of atopic dermatitis: A new method of measuring pediatric morbidity? Pediatr Dermatol 21:623-627, 2004.
21. Dawn A, Papoiu AD, Chan YH, et al. Itch characteristics in atopic dermatitis: Results of a web-based questionnaire. Br J Dermatol 160:642-644, 2009.
22. Schmitt J, Csotonyi F, Bauer A, and Meurer M. Determinants of treatment goals and satisfaction of patients with atopic eczema. J Dtsch Dermatol Ges 6:458-465, 2008.
23. Holm EA, Wulf HC, Stegmann H, and Jemec GB. Life quality assessment among patients with atopic eczema. Br J Dermatol 154:719-725, 2006.
24. Halvorsen JA, Lien L, Dalgard F, et al. Suicidal ideation, mental health problems, and social function in adolescents with eczema: A population-based study. J Invest Dermatol 134:1847-1854, 2014.
25. Langenbruch A, Radtke M, Franzke N, et al. Quality of health care of atopic eczema in Germany: Results of the national health care study AtopicHealth. J Eur Acad Dermatol Venereol 28: 719-726, 2014.
26. Camfferman D, Kennedy JD, Gold M, et al. Eczema, sleep, and behavior in children. J Clin Sleep Med 6:581-588, 2010.
27. Wittkowski A, Richards HL, Griffiths CE, and Main CJ. Illness perception in individuals with atopic dermatitis. Psychol Health Med 12:433-444, 2007.
28. Silverberg JI, and Simpson EL. Association between severe eczema in children and multiple comorbid conditions and increased healthcare utilization. Pediatr Allergy Immunol 24:476-486, 2013.
29. Chamlin SL, Mattson CL, Frieden IJ, et al. The price of pruritus: Sleep disturbance and cosleeping in atopic dermatitis. Arch Pediatr Adolesc Med 159:745-750, 2005.
30. Silverberg JI. Association between childhood eczema and headaches: An analysis of 19 US population-based studies. J Allergy Clin Immunol 137:492-499.e5, 2016.
31. Silverberg JI, and Paller AS. Association between eczema and stature in 9 US population-based studies. JAMA Dermatol 151: 401-409, 2015.
32. Filanovsky MG, Pootongkam S, Tamburro JE, et al. The financial and emotional impact of atopic dermatitis on children and their families. J Pediatr 169:284-290.e5, 2016
33. Su JC, Kemp AS, Varigos GA, and Nolan TM. Atopic eczema: Its impact on the family and financial cost. Arch Dis Child 76:159-162, 1997.
34. Malajian D, and Guttman-Yassky E. New pathogenic and therapeutic paradigms in atopic dermatitis. Cytokine 73:311-318, 2015.
35. Warner JA, McGirt LY, and Beck LA. Biomarkers of Th2 polarity are predictive of staphylococcal colonization in subjects with atopic dermatitis. BR J Dermatol 160:183-185, 2009.
36. Lo WT, Wang SR, Tseng MH, et al. Comparative molecular analysis of methicillin-resistant Staphylococcus aureus isolates from children with atopic dermatitis and healthy subjects in Taiwan. Br J Dermatol 162:1110-1116, 2010.
37. Ong PY, and Leung DY. Bacterial and viral infections in atopic dermatitis: A comprehensive review. Clin Rev Allergy Immunol 51:329-337, 2016.
38. Lowe AJ, Abramson MJ, Hosking CS, et al. The temporal sequence of allergic sensitization and onset of infantile eczema. Clin Exp Allergy 37:536-542, 2007.
39. Spergel JM, and Paller AS. Atopic dermatitis and the atopic march. J Allergy Clin Immunol 112(suppl.):S118-S127, 2003.
40. Marenholz I, Nickel R, Ruschendorf F, et al. Filaggrin loss-offunction mutations predispose to phenotypes involved in the atopic march. J Allergy Clin Immunol 118:866-871, 2006.
41. Suarez-Farinas M, Tintle SJ, Shemer A, et al. Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities. J Allergy Clin Immunol 2011;127:954-964.e1-4, 2011.
42. Howell MD, Fairchild HR, Kim BE, et al. Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation. J Invest Dermatol 128:2248-2258, 2008.
43. Jinnestal CL, Belfrage E, Back O, et al. Skin barrier impairment correlates with cutaneous Staphylococcus aureus colonization and sensitization to skin-associated microbial antigens in adult patients with atopic dermatitis. Int J Dermatol 53:27-33, 2014.
44. Strom MA, Fishbein AB, Paller AS, et al. Association between atopic dermatitis and attention deficit hyperactivity disorder in U.S. children and adults. Br J Dermatol 175:920-929, 2016.
45. Strom MA, and Silverberg JI. Eczema is associated with childhood speech disorder: A retrospective analysis from the National Survey of Children's Health and the National Health Interview Survey. J Pediatr 168:185-192.e4, 2016.
46. Yu SH, and Silverberg JI. Association between atopic dermatitis and depression in US adults. J Invest Dermatol 135:3183-3186, 2015.
47. Dalgard FJ, Gieler U, Tomas-Aragones L, et al. The psychological burden of skin diseases: A cross-sectional multicenter study among dermatological out-patients in 13 European countries. J Invest Dermatol 135:984-991, 2015.
48. Drury KE, Schaeffer M, and Silverberg JI. Association between atopic disease and anemia in US children. JAMA Pediatr 170: 29-34, 2016.
49. Silverberg JI, Joks R, and Durkin HG. Allergic disease is associated with epilepsy in childhood: A US population-based study. Allergy 69:95-103, 2014.
50. Garg N, and Silverberg JI. Association between childhood allergic disease, psychological comorbidity, and injury requiring medical attention. Ann Allergy Asthma Immunol 112:525-532, 2014.
51. Silverberg JI. Association between childhood atopic dermatitis, malnutrition, and low bone mineral density: A US population-based study. Pediatr Allergy Immunol 26:54-61, 2015.
52. Garg N, and Silverberg JI. Association between eczema and increased fracture and bone or joint injury in adults: A US population-based study. JAMA Dermatol 151:33-41, 2015.
53. Simpson EL, Bieber T, Eckert L, et al. Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adults. J Am Acad Dermatol 74:491-498, 2016.
54. Sidbury R, Davis DM, Cohen DE, et al. Guidelines of care for the management of atopic dermatitis: Section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol 71:327-349, 2014.
55. Uluckan O, Jimenez M, Karbach S, et al. Chronic skin inflammation leads to bone loss by IL-17-mediated inhibition of Wnt signaling in osteoblasts. Sci Transl Med 8:330ra37, 2016.
56. Li WQ, Han JL, Manson JE, et al. Psoriasis and risk of nonfatal cardiovascular disease in U.S. women: A cohort study. Br J Dermatol 166:811-818, 2012.
57. Zhang A, and Silverberg JI. Association of atopic dermatitis with being overweight and obese: A systematic review and metaanalysis. J Am Acad Dermatol 72:606-616.e4, 2015.
58. Silverberg JI. Atopic disease and cardiovascular risk factors in US children. J Allergy Clin Immunol 137:938-940.e1, 2016.
59. Silverberg JI, and Greenland P. Eczema and cardiovascular risk factors in 2 US adult population studies. J Allergy Clin Immunol 135:721-728.e6, 2015.
60. Silverberg JI, Song J, Pinto D, et al. Atopic dermatitis is associated with less physical activity in US adults. J Invest Dermatol 136:1714-1716, 2016.
61. Caffarelli C, Bacchini PL, Gruppi L, and Bernasconi S. Exerciseinduced bronchoconstriction in children with atopic eczema. Pediatr Allergy Immunol 16:655-661, 2005.
62. Silverberg JI. Association between adult atopic dermatitis, cardiovascular disease, and increased heart attacks in three population-based studies. Allergy 70:1300-1308, 2015.
63. Su VY, Chen TJ, Yeh CM, et al. Atopic dermatitis and risk of ischemic stroke: A nationwide population-based study. Ann Med 46:84-89, 2014.
64. Andersen YM, Egeberg A, Gislason GH, et al. Risk of myocardial infarction, ischemic stroke, and cardiovascular death in patients with atopic dermatitis. J Allergy Clin Immunol 138: 310-312.e3, 2016.
65. Drucker AM, Li WQ, Cho E, et al. Atopic dermatitis is not independently associated with nonfatal myocardial infarction or stroke among US women. Allergy 71:1496-1500, 2016.
66. Haeck IM, ten Berge O, van Velsen SG, et al. Moderate correlation between quality of life and disease activity in adult patients with atopic dermatitis. J Eur Acad Dermatol Venereol 26:236-241, 2012.
67. Charman CR, Venn AJ, and Williams HC. The patient-oriented eczema measure: Development and initial validation of a new tool for measuring atopic eczema severity from the patients' perspective. Arch Dermatol 140:1513-1519, 2004.
68. Finlay AY, and Khan GK. Dermatology Life Quality Index (DLQI)-A simple practical measure for routine clinical use. Clin Exp Dermatol 19:210-216, 1994.
69. Heinl D, Prinsen CA, Deckert S, et al. Measurement properties of adult quality-of-life measurement instruments for eczema: A systematic review. Allergy 71:358-370, 2015.
70. Lewis-Jones MS, and Finlay AY. The Children's Dermatology Life Quality Index (CDLQI): Initial validation and practical use. Br J Dermatol 132:942-949, 1995.